Eton Pharmaceuticals, Inc.
General ticker "ETON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $423.0M (TTM average)
Eton Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 38.0%.
Estimated limits based on current volatility of 2.4%: low 14.91$, high 15.64$
Factors to consider:
- Total employees count: 31 as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Strategic risks and growth management, Regulatory and compliance, Cybersecurity threats, Manufacturing disruptions, Supply chain disruptions
- Current price 13.9% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.76$, 16.48$]
- 2025-12-31 to 2026-12-31 estimated range: [6.18$, 13.30$]
Financial Metrics affecting the ETON estimates:
- Positive: with PPE of -85.1 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Industry operating cash flow (median)
- Negative: Inventory ratio change, % of 25.28 > 0.82
- Positive: 19.35 < Shareholder equity ratio, % of 32.09 <= 42.53
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 0.04 < Operating cash flow per share per price, % of 0.29
Short-term ETON quotes
Long-term ETON plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $21.25MM | $31.64MM | $39.01MM |
| Operating Expenses | $29.51MM | $32.83MM | $41.61MM |
| Operating Income | $-8.26MM | $-1.19MM | $-2.60MM |
| Non-Operating Income | $-0.76MM | $0.50MM | $-1.21MM |
| R&D Expense | $4.00MM | $3.32MM | $3.25MM |
| Income(Loss) | $-9.02MM | $-0.69MM | $-3.81MM |
| Taxes | $0.00MM | $0.25MM | $0.01MM |
| Profit(Loss)* | $-9.02MM | $-0.94MM | $-3.82MM |
| Stockholders Equity | $13.08MM | $15.48MM | $24.43MM |
| Inventory | $0.56MM | $0.91MM | $15.23MM |
| Assets | $25.03MM | $31.74MM | $76.12MM |
| Operating Cash Flow | $4.82MM | $6.82MM | $0.97MM |
| Capital expenditure | $2.79MM | $0.78MM | $0.03MM |
| Investing Cash Flow | $-2.79MM | $-0.78MM | $-40.01MM |
| Financing Cash Flow | $-0.13MM | $-0.96MM | $32.59MM |
| Earnings Per Share** | $-0.36 | $-0.04 | $-0.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.